This is a competing renewal application that requests continued support for providing pre- and post-doctoral trainees with strong methodological and practical training in quantitative cancer research. The application leverages a unique combination of strengths from the Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute (DFCI) and Dana-Farber / Harvard Cancer Center. This training program, now in its 34th year, draws upon a distinguished faculty, consisting of biostatisticians and computational biologists, as well as world renowned experts in cancer treatment and research. Its overarching goal is to provide the trainees with all essential elements of training needed to successfully undertake modern cancer research. The specific goals of this training program are to train students and postdoctoral fellows to be (1) quantitative scientists in cancer research, who are capable of using probability, statistics, computer science and mathematics to increase our knowledge and understanding of cancer; (2) strong team leaders/players as well as excellent communicators in a cancer research environment, who can effectively disseminate their research results and assume active roles in the design, analysis and interpretation of cancer clinical trials, cancer population studies and cancer genomic studies. All predoctoral students supported by this training grant are required to take a concentration in cancer-related courses. During their first and second summer periods in the program, students are required to participate in research activities of the DFCI or DF/HCC, performed under the supervision of faculty mentor/trainers affiliated in the program. Afterwards, many of these students will take up residence at the DFCI or elsewhere at DF/HCC and continue their research in cancer, which eventually evolves into their dissertation projects. All the postdoctoral fellows are closely involved with the practice of quantitative sciences in cancer and are typically in residence at the DFCI. All trainees are required to actively participate in the a working group seminar series on quantitative issues in cancer research, which serves as a primary forum at Harvard to discuss current issues and challenges on this topic, as well as in several of the DF/HCC sponsored symposia and event. This proposal requests 5 years of funding to support 10 pre-doctoral students and 1 post-doctoral fellow annually.
The training program is to train students and postdoctoral fellows to be high quality quantitative researchers who are capable of conducting cutting edge methodological and collaborative research in cancer clinical trials, computational biology, cancer genomics, cancer epidemiology and population science. Also, the program trains quantitative researchers to become strong team leaders/players as well as excellent communicators in a cancer research environment, and to enable them to effectively disseminate their research results and to assume active roles in the design, analysis and interpretation of, for example, cancer genomic studies, cancer clinical trials and cancer prevention trials.
|Braun, Danielle; Gorfine, Malka; Katki, Hormuzd A et al. (2018) Nonparametric Adjustment for Measurement Error in Time-to-Event Data: Application to Risk Prediction Models. J Am Stat Assoc 113:14-25|
|Patil, Prasad; Parmigiani, Giovanni (2018) Training replicable predictors in multiple studies. Proc Natl Acad Sci U S A 115:2578-2583|
|Sun, Ryan; Horiguchi, Miki; Wei, Lee-Jen (2018) Interpreting the Benefit of Trifluridine/Tipiracil in Metastatic Colorectal Cancer With Respect to Progression-Free Survival and Overall Survival. J Clin Oncol 36:1378-1379|
|Patro, Rob; Duggal, Geet; Love, Michael I et al. (2017) Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods 14:417-419|
|Collado-Torres, Leonardo; Nellore, Abhinav; Frazee, Alyssa C et al. (2017) Flexible expressed region analysis for RNA-seq with derfinder. Nucleic Acids Res 45:e9|
|Chipman, J; Braun, D (2017) Simpson's paradox in the integrated discrimination improvement. Stat Med 36:4468-4481|
|Braun, Danielle; Gorfine, Malka; Parmigiani, Giovanni et al. (2017) Propensity scores with misclassified treatment assignment: a likelihood-based adjustment. Biostatistics 18:695-710|
|Teng, Mingxiang; Love, Michael I; Davis, Carrie A et al. (2016) A benchmark for RNA-seq quantification pipelines. Genome Biol 17:74|
|Lazar, Ann A; Bonetti, Marco; Cole, Bernard F et al. (2016) Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP. Clin Trials 13:169-79|
|Jazi?, Ina; Schrag, Deborah; Sargent, Daniel J et al. (2016) Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research. J Natl Cancer Inst 108:|
Showing the most recent 10 out of 90 publications